Empagliflozin preserves kidney function in heart attack patients
SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease.
SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease.